Stocks
ImmunoGen (IMGN) EBITDA US GAAP (year values) |
|||||||||
| 2018 | 2019 | 2020 | 2021 | 2022 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -153.5 | -65.7 | -19.7 | -124.2 | -215.8 | 57.5 | ||
| Changes by years, y/y, % | +109% | -57% | -70% | +531% | +74% | +24.1% | |||
ImmunoGen. EBITDA US GAAP, bln rub
ImmunoGen. EBITDA US GAAP, changes, %
ImmunoGen. EBITDA US GAAP, sum by quarters, bln rub
ImmunoGen (IMGN) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q2 | 2023Q4 | 2024Q1 | 2023Q3 | LTM ? | |||
| EBITDA, bln rub | ? | 30.6 | -1.87 | -2.29 | 30.6 | 31.1 | 57.5 | |
| Changes by years, y/y, % | -139% | -97% | -96% | -181% | -140% | |||
| Changes by quarters, q/q, % | -181% | -106% | +23% | -1 437% | +1% | |||
